Therapeutic efficiency of Tamoxifen/Orlistat nanocrystals against solid ehrlich carcinoma via targeting TXNIP/HIF1-α/MMP-9/P27 and BAX/Bcl2/P53 signaling pathways.

MLA

El-Masry, Thanaa A., et al. “Therapeutic Efficiency of Tamoxifen/Orlistat Nanocrystals against Solid Ehrlich Carcinoma via Targeting TXNIP/HIF1-α/MMP-9/P27 and BAX/Bcl2/P53 Signaling Pathways.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 180, Nov. 2024, p. 117429. EBSCOhost, https://doi.org/10.1016/j.biopha.2024.117429.

APA

El-Masry, T. A., El-Nagar, M. M. F., Oriquat, G. A., Alotaibi, B. S., Saad, H. M., El Zahaby, E. I., & Ibrahim, H. A. (2024). Therapeutic efficiency of Tamoxifen/Orlistat nanocrystals against solid ehrlich carcinoma via targeting TXNIP/HIF1-α/MMP-9/P27 and BAX/Bcl2/P53 signaling pathways. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 180, 117429. https://doi.org/10.1016/j.biopha.2024.117429

Chicago

El-Masry, Thanaa A, Maysa M F El-Nagar, Ghaleb Ali Oriquat, Badriyah S Alotaibi, Hebatallah M Saad, Enas I El Zahaby, and Hanaa A Ibrahim. 2024. “Therapeutic Efficiency of Tamoxifen/Orlistat Nanocrystals against Solid Ehrlich Carcinoma via Targeting TXNIP/HIF1-α/MMP-9/P27 and BAX/Bcl2/P53 Signaling Pathways.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 180 (November): 117429. doi:10.1016/j.biopha.2024.117429.